| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Thursday - May 16, 2024 |
|||||||||
| Q1 FY25 | $0.60 | $0.52 | $161.51B | $159.57B |
NASDAQ |
||||
| Q2 FY24 | $8.53 | $7.86 | $15B | $13.31B |
NYSE |
||||
| Q2 FY24 | $2.09 | $1.99 | $6.65B | $6.54B |
NASDAQ |
||||
| Q4 FY24 | $0.97 | $0.83 | $3.39B | $3.37B |
NYSE |
||||
|
Flowers Foods
FLO
|
Q1 FY24 | $0.37 | $0.41 | $1.58B | $1.58B |
NYSE |
|||
| - | $11.09 | $9.63 | $1.57B | $1.55B |
NYSE |
||||
|
Under Armour
UA
|
Q4 FY24 | $0.11 | $0.08 | $1.33B | $1.33B |
NYSE |
|||
| Q4 FY24 | $0.31 | $0.09 | $1.40B | $1.31B |
NASDAQ |
||||
|
Copart
CPRT
|
Q3 FY24 | $0.39 | $0.39 | $1.13B | $1.11B |
NASDAQ |
|||
|
Advanced Drainage Systems
WMS
|
Q4 FY24 | $1.21 | $1.01 | $653.84M | $611.99M |
NYSE |
|||
|
Doximity
DOCS
|
Q4 FY24 | $0.25 | $0.20 | $118.06M | $116.41M |
NYSE |
|||
|
Barings Corporate Investors
MCI
|
- | $0.42 | - | $10.27M | - |
NYSE |
|||
|
Barings Participation Investors
MPV
|
- | $0.39 | - | $4.99M | - |
NYSE |
|||
|
Replimune Group
REPL
|
- | -$0.82 | -$0.86 | $4.04M | - |
NASDAQ |
|||
|
Exicure
XCUR
|
- | -$3.05 | - | - | $3.90M |
NASDAQ |
|||
|
Knightscope
KSCP
|
- | -$4.00 | -$0.06 | $2.25M | $2M |
NASDAQ |
|||
|
Falcon's Beyond Global
FBYD
|
- | $1.53 | - | $1.52M | - |
NASDAQ |
|||
|
Mill City Ventures III
MCVT
|
- | -$0.07 | - | $857.16K | - |
NASDAQ |
|||
|
AIM ImmunoTech
AIM
|
Q1 FY24 | -$12.00 | -$0.11 | $40K | - |
AMEX |
|||
|
CEL-SCI
CVM
|
- | -$4.20 | -$3.90 | - | - |
AMEX |
|||
|
Contineum Therapeutics
CTNM
|
- | -$3.55 | -$0.46 | - | - |
NASDAQ |
|||
| Show 11 more companies | |||||||||
